When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

The surface of Earth is finite. We can measure it. If it was expanding, then its size would grow with time. And once again, good ol' Earth helps us understand what the universe might be doing beyond ...

Is the universe infinite? It's one of the most profound questions we can ask, and here's the short answer: We don't know. While we have learned a great deal about the universe, a portion of the cosmos ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After four years of regularly introducing news maps, gameplay modes, and equipment for Halo Infinite, Halo Studios has announced that it is releasing the last major update for the game on Nov. 18.

This month’s content update for Halo Infinite is its last, as the team focuses on ‘multiple’ Halo titles in development. This month’s content update for Halo Infinite is its last, as the team focuses ...

Halo Infinite is getting one more major content update that will also be its last, as the developers are shifting to work on other upcoming games. When you purchase through links on our site, we may ...